GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » 5-Year Yield-on-Cost %
中文

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) 5-Year Yield-on-Cost %

: 2.38 (As of Today)
View and export this data going back to . Start your Free Trial

Carl Zeiss Meditec AG's yield on cost for the quarter that ended in Dec. 2023 was 2.38.


The historical rank and industry rank for Carl Zeiss Meditec AG's 5-Year Yield-on-Cost % or its related term are showing as below:

CZMWF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.53   Med: 1.93   Max: 4.31
Current: 2.38

During the past 13 years, Carl Zeiss Meditec AG's highest Yield on Cost was 4.31. The lowest was 0.53. And the median was 1.93.


CZMWF's 5-Year Yield-on-Cost % is ranked worse than
51.13% of 311 companies
in the Medical Devices & Instruments industry
Industry Median: 2.31 vs CZMWF: 2.38
Competitive Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carl Zeiss Meditec AG 5-Year Yield-on-Cost % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's 5-Year Yield-on-Cost % falls into.


Carl Zeiss Meditec AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Carl Zeiss Meditec AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Carl Zeiss Meditec AG  (OTCPK:CZMWF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Carl Zeiss Meditec AG 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » 5-Year Yield-on-Cost %
Comparable Companies
XTER:GXI XTER:FIE FRA:PHH2 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543 XSWX:STMN BAX COO HOLX TSE:7733 TSE:6869 TFX
Traded in Other Exchanges
CZMWY:USA 1AFX:Italy AFXd:UK 0DHC:UK AFX:Germany AFX:Austria
Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Website
https://www.zeiss.com
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.